You are viewing: US Diagnostic Imaging Market analysis
Part of: Diagnostic Imaging Market (Global)

The US Diagnostic Imaging Market was valued at $8828.8 Million in 2025 and projected to reach to $10970 Million by 2030, representing a compound annual growth rate of 4.4%. The US diagnostic imaging market is positioned for sustained growth through 2030, supported by an aging population requiring increased diagnostic services and continuous technological innovation in imaging modalities.

US Diagnostic Imaging Market Trends and Insights

  • The US market benefits from advanced healthcare infrastructure, high adoption of imaging technologies, and strong reimbursement mechanisms that support continued investment in diagnostic capabilities.
  • Aging demographics and rising prevalence of chronic diseases in the US are driving demand for early detection and monitoring through imaging modalities. In the US, technological advancements in imaging equipment—including AI-powered diagnostics, portable imaging systems, and hybrid imaging platforms—are reshaping the competitive landscape.
  • The US market is characterized by significant capital expenditure from hospitals and diagnostic centers seeking to modernize their imaging departments.
  • Regulatory support and favorable healthcare policies in the US continue to facilitate market expansion through 2030. The US diagnostic imaging sector remains highly competitive, with established manufacturers and emerging innovators competing on image quality, operational efficiency, and integrated software solutions.
  • Market consolidation and strategic partnerships among US-based and international players are expected to accelerate, further strengthening the market's growth trajectory toward 2030..

Key Market Statistics

  • CAGR (2025-2030) 4.4% CAGR
  • Market Size, 2025 ~USD 8828.8 Million
  • Forecast, 2030 ~USD 10970 Million
  • Country US

US Diagnostic Imaging Market Overview

Market Valuation :

The US diagnostic imaging market is valued at $8,828.8 million in 2025, with projected growth to $10,970 million by 2030, driven by technological advancement and healthcare infrastructure investment.

Steady Growth Trajectory :

A consistent 4.4% CAGR through 2030 reflects stable demand for imaging services across US healthcare systems, supported by insurance reimbursement policies and clinical adoption rates.

Advanced Healthcare Infrastructure :

The US benefits from world-class medical facilities, high-tech imaging equipment deployment, and strong healthcare spending that accelerates adoption of next-generation diagnostic technologies.

Demographic Tailwinds :

An aging US population drives increased demand for diagnostic imaging services, as older demographics require more frequent screening, monitoring, and disease detection across multiple clinical specialties.

US Diagnostic Imaging Market Dynamics

  • Strong reimbursement mechanisms and healthcare infrastructure investments create favorable conditions for market expansion.
  • Healthcare providers are increasingly adopting advanced imaging technologies to improve diagnostic accuracy and patient outcomes, while digital transformation initiatives enhance operational efficiency.
  • The market will benefit from rising prevalence of chronic diseases and growing demand for early disease detection, positioning the US as a key growth driver in the global diagnostic imaging sector..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Stryker Corporation
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • The US diagnostic imaging market will expand from $8,828.8M in 2025 to $10,970M by 2030 at a 4.4% CAGR.
      • Advanced healthcare infrastructure and strong reimbursement policies position the US as a mature, high-value market for imaging technologies.
      • AI integration, portable systems, and hybrid imaging platforms are driving innovation and competitive differentiation in the US market.
      • Aging demographics and chronic disease prevalence in the US create sustained demand for diagnostic imaging through 2030.

      Diagnostic Imaging Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment ULTRA-HIGH-FIELD (Field Strength)
      Forecast Period 2025–2030
      Growth Rate CAGR of 4.4% from 2025 to 2030
      Largest Segment HOSPITALS (End User)
      Market Size Base Year (Billions) ~USD 26.53 (2025)
      Revenue Forecast (Billions) ~USD 32.9 (2030)
      Segments Covered Application, Modality, Type, Technology, Portability, Architecture, Field Strength, End User

      US Diagnostic Imaging Market Report Segmentation

      8 segment dimensions are covered across the global market.

      By Application

      • Brain & Neurological Mri
      • Breast Mri
      • Cardiac Mri
      • Cardiology
      • Dentistry
      • Fluoroscopy
      • General Radiography
      • Neurology
      • Obstetrics/Gynecology
      • Oncology
      • Other Applications
      • Pelvic & Abdominal Mri
      • Radiology/General Imaging
      • Spine & Musculoskeletal Mri
      • Urology
      • Vascular
      • Vascular Mri

      By Modality

      • Ct Scanners
      • Mammography Systems
      • Mri Systems
      • Nuclear Imaging Systems
      • Ultrasound
      • Ultrasound Systems
      • X-Ray Imaging Systems

      By Type

      • Analog
      • Analog X-Ray Imaging Systems
      • Cone-Beam
      • Conventional
      • Conventional Ct
      • Digital
      • Digital X-Ray Imaging Systems
      • High-Slice
      • Hybrid Spect
      • Hybrid Spect Systems
      • Low-Slice
      • Mid-Slice
      • Pet
      • Pet Systems
      • Spect
      • Spect Systems

      By Technology

      • 2D
      • 2D Ultrasound
      • 3D & 4D
      • 3D And 4D Ultrasound
      • Contrast-Enhanced
      • Contrast-Enhanced Ultrasound Systems
      • Doppler Imaging
      • Doppler Imaging Systems

      By Portability

      • Compact/Portable
      • Portable
      • Portable X-Ray
      • Stationary
      • Stationary X-Ray
      • Trolley/Cart-Based

      By Architecture

      • Closed
      • Open

      By Field Strength

      • High & Very High-Field
      • High And Very-High-Field
      • Low-To-Mid-Field
      • Ultra-High-Field

      By End User

      • Diagnostic Imaging Centers
      • Hospitals
      • Other End Users

      Target Audience

      • Healthcare Providers & Hospital Systems : US hospitals and imaging centers need market data to optimize capital expenditure on diagnostic equipment, plan service expansion, and align imaging capabilities with patient demand forecasts.
      • Medical Device Manufacturers : Imaging equipment and technology companies require US-specific market intelligence to guide product launches, competitive positioning, and sales strategy in the world's largest diagnostic imaging market.
      • Private Equity & Investment Firms : Investors evaluating healthcare acquisitions and portfolio companies need detailed US market sizing and growth projections to assess investment returns and identify consolidation opportunities.
      • Healthcare Consultants & Advisors : Management consulting firms and healthcare advisors use market data to support client strategy development, feasibility studies, and business case development for imaging service expansion.
      • Insurance & Reimbursement Specialists : Payers and reimbursement professionals need US market analysis to understand imaging utilization trends, cost drivers, and coverage policy implications for diagnostic services.

      Key Companies in the US Diagnostic Imaging Market

      CompanyHQOwnershipStrongest segments
      TOSHIBA CORPORATIONJapanPrivate CompanyEnergy Systems & Solutions,Infrastructure Systems & Solutions,Electronic Devices and Storage Solutions,
      AT&SCanadaPublic CompanyCustom automated manufacturing and assembly systems,Pre- and post-automation lifecycle services,Contract manufacturing and integration services,
      HEALTHFUSION INC.United StatesPrivate CompanyMediTouch EHR (clinical module),Practice Management & Scheduling,Clearinghouse & Revenue Cycle Transactions,
      UNILABSSwitzerlandPrivate CompanyCore laboratory testing,Medical imaging,Pathology and centres of excellence,
      UNITED IMAGING HEALTHCARE CO., LTD.ChinaPublic CompanyMagnetic Resonance Imaging,Computed Tomography,Molecular Imaging (PET/CT, SPECT),
      SIEMENS HEALTHINEERSGermanyPublic Company
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
      KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnostic Imaging (MR, CT, X-ray, Ultrasound),Image Guided Therapy Systems and Devices,Monitoring and Enterprise Informatics,
      FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductors, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document services, graphic communications, inkjet),
      CANONJapanPublic CompanyPrinting Business Unit (office, production, large-format, document solutions),Imaging Business Unit (cameras, lenses, network cameras, cinema/broadcast),Medical Business Unit (diagnostic imaging, ophthalmology, IVD, healthcare IT),
      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.ChinaPublic CompanyPatient monitoring, anesthesia, ventilators, and defibrillation,Ultrasound and radiology imaging,In-vitro diagnostics (CLIA, chemistry, hematology),
      ESAOTE S.P.AItalyPrivate CompanyUltrasound diagnostic imaging systems,Dedicated MRI systems (MSK, weight-bearing, head),Healthcare IT software (radiology, cardiology, oncology),
      SHIMADZU CORPORATIONJapanPublic CompanyAnalytical and Measuring Instruments,Medical Systems (Imaging and Fluorescence),Industrial and Vacuum Machinery,
      HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Panther/Aptima and related assays),Breast Health (3D mammography, biopsy, imaging software, service),GYN Surgical (MyoSure, NovaSure, Acessa, Fluent, CoolSeal),
      AGFA-GEVAERT GROUPBelgiumPublic CompanyHealthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray film, and hardcopy,Sign and display and packaging printers, inks, and software,
      CURVEBEAM AI, LTD.United StatesPublic CompanyLower extremity weight-bearing CT (LineUP, pedCAT, pedCAT Premium, TALAS, Autometrics, Axiometrics),HiRise bilateral weight-bearing CT (multi-joint, including hip and full lower limb),Upper extremity and general point-of-care CT (InReach, OSSView, CubeVue, custom cloud platforms),

      TOSHIBA CORPORATION

      Toshiba Corporation is a private company founded in 1875 and based in Japan with 106,648 employees.

      AT&S

      AT&S is a public company founded in 1978 and based in Canada with 7,000 employees.

      HEALTHFUSION INC.

      HealthFusion Inc. is a private company founded in 1998 and based in the United States with 120 employees.

      UNILABS

      Unilabs is a private company founded in 1987 and based in Switzerland with 1,897 employees.

      UNITED IMAGING HEALTHCARE CO., LTD.

      United Imaging Healthcare Co., Ltd. is a public company founded in 2011 and based in China with 8,703 employees.

      SIEMENS HEALTHINEERS

      Siemens Healthineers is a public company founded in 1896 and based in Germany with 72,369 employees.

      GE HEALTHCARE

      GE Healthcare is a public company founded in 2022 and based in the United States with 54,000 employees.

      KONINKLIJKE PHILIPS N.V.

      Koninklijke Philips N.V. is a public company founded in 1891 and based in the Netherlands with 64,317 employees.

      FUJIFILM CORPORATION

      Fujifilm Corporation is a public company founded in 1934 and based in Japan with 73,526 employees.

      CANON

      Canon is a public company founded in 1933 and based in Japan with 165,547 employees.

      SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

      Shenzhen Mindray Bio-Medical Electronics Co., Ltd. is a public company founded in 1991 and based in China with 21,288 employees.

      ESAOTE S.P.A

      Esaote S.p.A. is a private company founded in 1982 and based in Italy with 1,067 employees.

      SHIMADZU CORPORATION

      Shimadzu Corporation is a public company founded in 1875 and based in Japan with 14,649 employees.

      HOLOGIC, INC.

      Hologic, Inc. is a private company founded in 1985 and based in the United States with 7,070 employees.

      AGFA-GEVAERT GROUP

      Agfa-Gevaert Group is a public company founded in 1867 and based in Belgium with 4,211 employees.

      CURVEBEAM AI, LTD.

      CurveBeam AI, Ltd. is a public company founded in 2009 and based in the United States with 50 employees.

      Reasons to Buy this Report

      • Market Size & Growth Data : Access precise US market valuation ($8,828.8M in 2025) and 2030 forecasts with detailed CAGR analysis to support strategic planning and investment decisions in the diagnostic imaging sector.
      • Competitive Landscape Intelligence : Understand market dynamics specific to the US healthcare system, including reimbursement structures, regulatory environment, and competitive positioning of imaging technology providers.
      • Demographic & Clinical Insights : Leverage data on aging US population trends and disease prevalence patterns driving diagnostic imaging demand across radiology, cardiology, oncology, and other clinical specialties.
      • Technology Adoption Trends : Identify emerging imaging modalities and digital health integration opportunities within US healthcare systems to guide product development and market entry strategies.
      • Investment & Expansion Strategy : Make informed decisions on facility expansion, equipment procurement, and partnership opportunities based on comprehensive US market forecasts and regional growth projections.

      Frequently asked questions

      What is the current size of the US diagnostic imaging market in 2025?

      The US diagnostic imaging market is valued at $8,828.8 million in 2025.

      What is the projected size of the US diagnostic imaging market by 2030?

      The US diagnostic imaging market is projected to reach $10,970 million by 2030.

      What is the growth rate of the US diagnostic imaging market?

      The US diagnostic imaging market is expected to grow at a compound annual growth rate (CAGR) of 4.4% from 2025 to 2030.

      What factors are driving growth in the US diagnostic imaging market?

      Key growth drivers in the US include aging demographics, rising chronic disease prevalence, technological advancements such as AI-powered diagnostics, and strong healthcare infrastructure with favorable reimbursement policies.

      Which technologies are transforming the US diagnostic imaging landscape?

      AI-powered diagnostics, portable imaging systems, hybrid imaging platforms, and integrated software solutions are the primary technologies reshaping the US diagnostic imaging market.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the diagnostic imaging market. Exhaustive secondary research was done to collect information on the peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

      Secondary Research

      The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial diagnostic imaging market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the diagnostic imaging market. The primary sources from the demand side include medical OEMs, CDMOs, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

      A breakdown of the primary respondents is provided below:

      Diagnostic Imaging Market

      Note 1: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

      Note 2: D-level executives include directors of operations, directors of finance, directors of marketing, and directors of product management

      Note 3: C-level executives include chief executive officers, chief financial officers, chief operating officers, and chief marketing officers.

      Note 4: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = < USD 50 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      In this report, the size of the diagnostic imaging market was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insights gathered during the primary and secondary research phases. Secondary research included studying the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

      Segmental revenues were calculated based on the revenue mapping of major product providers to calculate the global market value. This process involves the following steps:

      • Generating a list of major global players operating in the diagnostic imaging market
      • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/category)
      • Mapping the revenues of major players to cover a major share of the global market, as of 2024
      • Extrapolating the global value of the diagnostic imaging market industry
      Diagnostic Imaging Market

      Data Triangulation

      After arriving at the overall market size from the market size estimation process explained above, the global diagnostic imaging market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the diagnostic imaging market was validated using top-down and bottom-up approaches.

      Market Definition

      Diagnostic imaging involves the use of various diagnostic modalities to visualize a patient’s anatomy. This market addresses the industry focusing on various technologies used for the detection, monitoring, and diagnosis of different medical conditions. Different imaging modalities include computed tomography (CT), ultrasound, X-ray imaging, MRI, nuclear imaging, and mammography technologies. These modalities help healthcare professionals to visualize the internal structure and other surrounding tissues. Diagnostic imaging equipment is primarily used in hospitals, diagnostic imaging centers, and ambulatory imaging centers.

      Stakeholders

      • Senior Management
      • End Users
      • R&D Department
      • Finance/Procurement Department

      Report Objectives

      • To define, describe, and forecast the size of the diagnostic imaging market based on modality, application, end user, and region
      • To provide detailed information regarding the major factors influencing the growth potential of the global diagnostic imaging market (drivers, restraints, opportunities, challenges, and trends)
      • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the global diagnostic imaging market
      • To analyze key growth opportunities in the global diagnostic imaging market for key stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa
      • To profile the key players in the diagnostic imaging market and comprehensively analyze their market shares and core competencies
      • To track and analyze the competitive developments undertaken in the global diagnostic imaging market, such as product launches, agreements, expansions, alliances, and mergers & acquisitions

       

      Get the Full Diagnostic Imaging Market Report

      Full forecast, segment splits, and company analysis for all Diagnostic Imaging Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status